Order Article Reprints

Wang W, Wang X, Rajaei M, Youn JY, Zafar A, Deokar H, Buolamwini JK, Yang J, Foster JH, Zhou J, et al. Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action. Cancers. 2020; 12(12):3651. https://doi.org/10.3390/cancers12123651

Wang, Wei, Xinjie Wang, Mehrdad Rajaei, Ji Youn Youn, Atif Zafar, Hemantkumar Deokar, John K. Buolamwini, Jianhua Yang, Jennifer H. Foster, Jia Zhou, and et al. 2020. "Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action" Cancers 12, no. 12: 3651. https://doi.org/10.3390/cancers12123651

Wang, W., Wang, X., Rajaei, M., Youn, J. Y., Zafar, A., Deokar, H., Buolamwini, J. K., Yang, J., Foster, J. H., Zhou, J., & Zhang, R. (2020). Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action. Cancers, 12(12), 3651. https://doi.org/10.3390/cancers12123651